168047-46-9

Upstream product

• 168045-48-5 ethyl 2-<2,6-diaza-6-<(4-nitrophenyl)carbonyl>-3-oxobicyclo<5.4.0>undeca-1(7),8,10-trien-2-yl>acetate 
• 168045-47-4 2,6-diaza-6-<(4-nitrophenyl)carbonyl>bicyclo<5.4.0>undeca-1(7),8,10-trien-3-one 
• 122-04-3 4-nitro-benzoyl chloride 
• 7148-03-0 o-tolylbenzoic acid 
• 5755-07-7 2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one 
• 114772-35-9 4'-methylbiphenyl-2-carboxylic acid chloride 
• 168048-37-1 ethyl 2-<6-<(4-aminophenyl)carbonyl>-2,6-diaza-3-oxobicyclo<5.4.0>undeca-1(7),8,10-trien-2-yl>acetate 

Downstream Products

• 168046-38-6 1-ethoxycarbonylmethyl-5-{4-[N-2-(4-methylphenyl)benzoyl-N-methyl]aminobenzoyl}-1,3,4,5-tetrahydro-1,5-benzodiazepin-2(2H)-one 
• 168046-06-8 2-<2,6-diaza-6-<<4<<2-(4-methylphenyl)phenyl>carbonyl-amino>phenyl>carbonyl>-3-oxobicyclo<5.4.0>undeca-1(7),8,10-trien-2-yl>acetic acid 
• 168046-41-1 N-<4-<2,6-diaza-6-<2-(4-methylpiperazinyl)-2-oxoethyl>-5-oxobicyclo<5.4.0>undeca-1(7),8,10-trien-2-yl>carbonyl>phenyl<2-(4-methylphenyl)phenyl>formamide 

Relevant academic research and scientific papers

Synthesis and characterization of orally active nonpeptide vasopressin V2 receptor antagonists

The present study was undertaken to evaluate whether a novel series of 2,6-diaza-5-oxobicyclo[5.4.0]undeca-1(7),8,10-triene derivatives exhibited antagonistic activity for vasopressin V1 and V2 receptors. Most of these compounds were

Benzamide derivatives and pharmaceutical composition comprising the same

Compounds having the structure below STR1 and pharmaceutically acceptable salts thereof exhibit vasopressin antagonistic activity, vasodilating activity, hypotensive activity, activity for inhibiting saccharide release in the liver, activity for inhibitin